Dermoscopy-Guided High-Frequency Ultrasound Imaging of Subcentimeter Cutaneous and Subcutaneous Neurofibromas in Patients with Neurofibromatosis Type 1
Open Access
- 7 January 2026
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (2) , 475
Abstract
Background: Neurofibromatosis type 1 (NF1) is an autosomal dominant disorder characterized by cutaneous and subcutaneous neurofibromas, which impact quality of life. Dermoscopy-guided high-frequency ultrasound (DG-HFUS) integrates dermoscopy with 33 MHz ultrasound, enabling precise lesion localization and reproducible measurements. Objective: To characterize neurofibromas in NF1 patients using DG-HFUS and identify imaging parameters for diagnosis, monitoring, and treatment planning. Methods: 14 genetically confirmed NF1 patients underwent DG-HFUS imaging (Dermus SkinScanner). 100 neurofibromas were assessed for size, location, shape, contours, surface, echogenicity, global echogenicity, and posterior acoustic features. Results: Lesions were dermal (79%) or subcutaneous (21%), round (28%), ovoid (63%), or spiked (9%). Mean vertical and lateral diameters were 5.37 ± 2.66 mm and 2.28 ± 1.39 mm. All were hypoechoic; 62% homogeneous, 38% heterogeneous. Margins were well-defined in 57% and poorly defined in 43%. Posterior enhancement occurred in 3% and shadowing in 10%. Conclusions: DG-HFUS provides a detailed, reproducible assessment of neurofibromas, supporting differential diagnosis, surgical planning, and longitudinal monitoring. The evaluated imaging parameters offer objective insights for optimizing NF1 management. Future developments, including 3D reconstruction and AI-assisted analysis, may further enhance its clinical utility.Keywords
Funding Information
- National Research, Development and Innovation Fund, the National Research, and the Development and Innovation Office of Hungary—NKFIH (FK131916)
- Ministry for Culture and Innovation of Hungary from the National Research, Development and Innovation Fund (2020-1.1.5-GYORSÍTÓSÁV-2021-00015)
This publication has 54 references indexed in Scilit:
- Malignant and Benign Peripheral Nerve Sheath Tumors in a Single CenterJournal of Ultrasound in Medicine, 2023
- Neurofibromatosis type 1 system-based manifestations and treatments: a reviewNeurological Sciences, 2023
- Comparison of Cancer Prevalence in Patients With Neurofibromatosis Type 1 at an Academic Cancer Center vs in the General Population From 1985 to 2020JAMA Network Open, 2021
- Genetic basis of neurofibromatosis type 1 and related conditions, including mosaicismChild's Nervous System, 2020
- Noninvasive Imaging Tools in the Diagnosis and Treatment of Skin CancersAmerican Journal of Clinical Dermatology, 2018
- The use of electrodessication in the treatment of cutaneous neurofibromatosis: A retrospective patient satisfaction outcome assessmentJournal of Plastic, Reconstructive & Aesthetic Surgery, 2016
- Imaging of the malignant peripheral nerve sheath tumour with emphasis οn ultrasonography: correlation with MRIJournal of Ultrasound, 2014
- Carbon Dioxide Laser Treatment of Cutaneous NeurofibromasDermatology and Therapy, 2012
- Non-excision treatment of multiple cutaneous neurofibromas by laser photocoagulationLasers in Medical Science, 2007
- Spectrum of single‐ and multiexon NF1 copy number changes in a cohort of 1,100 unselected NF1 patientsGenes, Chromosomes and Cancer, 2005